Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
City of Hope Medical Center
City of Hope Medical Center
Nurix Therapeutics, Inc.
Verismo Therapeutics
Calibr, a division of Scripps Research
Novartis
AbbVie